Israeli technology which stops the spread of breast cancer is looking for Dutch partners for validation studies.
- Location Tel Aviv
- Industry Life sciences and health
- Online since 2019-12-23
Tel Aviv University is looking fro Dutch partners for validation studies for its technology which stops the spread of breast cancer.
Prof Noam Shomron and his team, at the Faculty of Medicine at Tel Aviv University, has shown that breast cancer metastasis can be prevented by treatment with specific microRNA molecules. The team has also deciphered the molecular mechanism associated with metastasis inhibition. In mouse models, local treatment prior to resection of the primary tumor prevents formation of metastatic lesions. The unmet need: While metastasis is the primary cause for mortality in breast cancer, cancer therapy lacks effective anti-metastatic strategies. The solution: Shomron has shown that in vivo delivery of microRNAs efficiently blocks breast cancer metastasis from spreading to lungs, liver and brain, in mice. The potential product: More effective individualized anti-metastatic therapy (Precision Medicine) based on DNA profiling and microRNA fitting. A patent is spending.
Go to website